Abdul Aziz Bin Aiderus

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Purpose: Hormone receptor-positive (HR+) breast cancer is clinically and biologically heterogeneous, and subgroups with different prognostic and treatment sensitivities need to be identified.Experimental Design: Research-based PAM50 subtyping and expression of additional genes was performed on 63 patients with HR+/HER2- disease randomly assigned to(More)
Purpose: Hormone receptor–positive (HRþ) breast cancer is clinically and biologically heterogeneous, and subgroups with different prognostic and treatment sensitivities need to be identified. Experimental Design: Research-based PAM50 subtyping and expression of additional genes was performed on 63 patients with HRþ/HER2 disease randomly assigned to(More)
  • 1